Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

Continuous model averaging for benchmark dose analysis: Averaging over distributional forms

On this page:

  • Overview
  • Downloads
When estimating a benchmark dose (BMD) from chemical toxicity experiments, model averaging is recommended by the World Health Organization and European Food Safety Authority. Though model averaging iswell studied forBMD estimation using dichotomous data, few studies investigate it forBMDestimation using continuous data. In this setting, model averaging a BMD pose additional problems as the assumed distribution is essential to many BMD de?nitions, and distributional uncertainty is underestimated when one distribution is chosen a priori. As model averaging averages over a probability model, there is no reason one cannot include distributional assumptions into the model average. Consequently, we de?ne a continuous model averaging approach over distributional models and show that it is superior to single distribution model averaging.

Impact/Purpose

As indicated by the recent incorporation of Bayesian model averaging for dichotomous response data (DMA) into the Agency's BMDS 3 series of dose-response modeling tools, as well as recent EPA Statisitical Workgroup activity and HERA research efforts, EPA will likely join the World Health Organization, European Food Safety Authority and NIH/NIEHS in recommending Bayesian model averaging for estimating a benchmark dose (BMD) from chemical toxicity experiments.  This paper describes an approach that EPA is considering for Bayesian model averaging of continuous response data (CMA) that is consistent and complimentary to the existing BMDS DMA tool. EPA plans to subject this CMA appraoch SWG and external peer review in FY21/FY22, preliminary to incorporating CMA into a future version of BMDS.

Citation

Wheeler, M., J. Cortiñas Abrahantes, M. Aerts, Jeff Gift, AND Allen Davis. Continuous model averaging for benchmark dose analysis: Averaging over distributional forms. John Wiley & Sons Incorporated, New York, NY, 33(5):1-11, (2022). [DOI: 10.1002/env.2728]

Download(s)

DOI: Continuous model averaging for benchmark dose analysis: Averaging over distributional forms
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on February 21, 2023
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.